0.8592
Schlusskurs vom Vortag:
$0.87
Offen:
$0.861
24-Stunden-Volumen:
375.75K
Relative Volume:
0.17
Marktkapitalisierung:
$16.89M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-23.15M
KGV:
-0.1296
EPS:
-6.6319
Netto-Cashflow:
$-16.93M
1W Leistung:
-7.96%
1M Leistung:
+17.23%
6M Leistung:
-80.43%
1J Leistung:
-54.78%
iBio Inc Stock (IBIO) Company Profile
Firmenname
iBio Inc
Sektor
Branche
Telefon
302-355-0650
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Vergleichen Sie IBIO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
IBIO
iBio Inc
|
0.8592 | 17.10M | 2.05M | -23.15M | -16.93M | -6.6319 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-05-28 | Eingeleitet | Chardan Capital Markets | Buy |
2021-11-29 | Eingeleitet | JMP Securities | Mkt Outperform |
2021-01-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-06-26 | Eingeleitet | Alliance Global Partners | Buy |
iBio Inc Aktie (IBIO) Neueste Nachrichten
What moving averages say about iBio Inc.M&A Rumor & Technical Pattern Based Signals - newser.com
Will breakout in iBio Inc. lead to full recoveryMarket Risk Analysis & Trade Opportunity Analysis Reports - newser.com
Contrasting iBio (IBIO) and The Competition - Defense World
Stock Analysis: Will iBio Inc benefit from green energy policiesJuly 2025 Breakouts & Low Drawdown Investment Strategies - khodrobank.com
Levels Update: Does KORE have a sustainable dividendVolume Spike & Advanced Swing Trade Entry Alerts - khodrobank.com
Is iBio Inc. a candidate for recovery playJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - newser.com
Is iBio Inc. showing signs of accumulationEarnings Risk Summary & Long-Term Safe Return Strategies - newser.com
Market Overview: Should I trade or invest in Lee Enterprises IncorporatedWeekly Trading Summary & Verified Technical Trade Signals - khodrobank.com
Comparing iBio Inc. in custom built stock radarsJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
Risk On: What is the PEG ratio of iBio Inc2025 Top Gainers & Community Supported Trade Ideas - khodrobank.com
How to forecast iBio Inc. trends using time seriesJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
Highs Report: Why is DB Gold Double Long ETN stock going downJuly 2025 Highlights & AI Powered Buy/Sell Recommendations - khodrobank.com
Aug Setups: Will iBio Inc benefit from green energy policies2025 Year in Review & Long-Term Safe Return Strategies - خودرو بانک
iBio (NYSEMKT:IBIO) Stock Price Down 4.2% – Here’s Why - Defense World
Critical Survey: iBio (IBIO) and Its Competitors - Defense World
What recovery options are there for iBio Inc.Risk Management & Weekly Top Performers Watchlists - newser.com
Downgrade Watch: Will IBIO outperform during market rallies2025 Performance Recap & Real-Time Stock Entry Alerts - khodrobank.com
Support Test: Will iBio Inc outperform its industry peersJuly 2025 Macro Moves & Growth Focused Stock Reports - khodrobank.com
Market Leaders: How do insiders feel about iBio IncVolume Spike & Growth Oriented Trade Recommendations - خودرو بانک
Smart Money: Can iBio Inc be recession proofInsider Buying & Safe Swing Trade Setups - khodrobank.com
Head-To-Head Survey: iBio (IBIO) versus The Competition - Defense World
Aug Mood: Is iBio Inc impacted by rising ratesDollar Strength & Weekly Top Stock Performers List - خودرو بانک
IPO Launch: How sensitive is iBio Inc to inflationJuly 2025 Institutional & Technical Buy Zone Confirmations - خودرو بانک
What machine learning models say about iBio Inc.July 2025 PostEarnings & Precise Buy Zone Identification - Newser
Is iBio Inc. still worth holding after the dipJuly 2025 Reactions & Accurate Buy Signal Alerts - Newser
What’s the recovery path for long term holders of iBio Inc.2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - Newser
Best data tools to analyze iBio Inc. stockMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - Newser
Sector ETF performance correlation with iBio Inc.GDP Growth & Safe Capital Growth Plans - Newser
Does iBio Inc. fit your quant trading modelJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Multi asset correlation models including iBio Inc.2025 Momentum Check & Safe Capital Preservation Plans - Newser
Big Picture: How cyclical is iBio Inc.’s revenue streamAnalyst Upgrade & Weekly Momentum Picks - Lancaster City Council
Ibio Inc’s Future at Risk: Reliance on Third-Party Licenses for Key Product Candidates - The Globe and Mail
Is a relief rally coming for iBio Inc. holdersWeekly Profit Report & Technical Buy Zone Confirmations - Newser
iBio Full Year 2025 Earnings: US$1.75 loss per share (vs US$4.03 loss in FY 2024) - Yahoo Finance
What hedge funds are buying iBio Inc.July 2025 Levels & Fast Gain Swing Trade Alerts - خودرو بانک
Can iBio Inc. be recession proofEarnings Overview Report & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
iBio, Inc. Reports Transformative Fiscal Year 2025 - TipRanks
Brookline Capital Markets reiterates Buy rating on iBio stock with $1.60 target - Investing.com India
What MACD and RSI say about iBio Inc.Market Sentiment Review & Entry Point Confirmation Signals - Newser
Brookline Capital Markets reiterates Buy rating on iBio stock with $1.60 target By Investing.com - Investing.com South Africa
Why is iBio Inc. stock going upJuly 2025 Update & Risk Controlled Swing Trade Alerts - خودرو بانک
Is iBio Inc. trending in predictive chart modelsWeekly Trade Report & AI Enhanced Trade Execution Alerts - Newser
IBio, Inc. Reports Earnings Results for the Full Year Ended June 30, 2025 - MarketScreener
iBio, Inc. SEC 10-K Report - TradingView
iBio (IBIO) Reports Revenue Growth and Strategic Advancements - GuruFocus
iBio Sets Sights on Clinic for Treatments of Obesity, Heart Disease - San Diego Business Journal
iBio Reports Fiscal Year 2025 Financial Results and Provides Cor - GuruFocus
iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update - The Manila Times
IBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update - MarketScreener
Finanzdaten der iBio Inc-Aktie (IBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):